Catalysts

PRODUCTS

  • VPX3469a
    300 kW Magnetron Transmitter: 3469 Series

    CPI EDB offers the 3469 magnetron transmitter system for use as a high-power source of RF power for outdoor-mounted radar applications. The transmitter cabinet contains the high voltage power supply, solid-state switch, and the high voltage tank assembly which includes the pulse transformer, energy storage high voltage capacitor, and filament power supply.

  • Leica Stellaris bucket
    STELLARIS DLS Digital Light Sheet Microscope

    Light Sheet Re-Imagined

    STELLARIS 5 and STELLARIS 8 Digital LightSheet (DLS) unite in one place a confocal system and a light sheet microscope – a unique combination aimed to make your research more versatile. The exclusive vertical design of DLS, enabled by Leica Microsystems’ proprietary TwinFlect mirrors, allows you to combine confocal and light sheet imaging in the same system, so you can easily adapt the microscopy method to your experimental needs.

  • Qorvo - QPM0106_PDP
    1.0 - 6.0 GHz 35 Watt GaN Power Amplifier: QPM0106

    The QPM0106 is a packaged, high-power amplifier fabricated on Qorvo's production 0.25 um GaN on SiC process that operates from 1.0 - 6.0 GHz and provides 45.4 dBm (35 W) of saturated output power.

  • Human Brain cerebellum-GettyImages-2150929983
    Gain Objective Measures And Subjective Measures Of CNS Function

    NeuroCart is a fully self-contained, mobile CNS test battery developed in-house at CHDR, offering the possibility to measure a wide range of CNS effects in a pharmacological context.

  • Isolated Antibody Drug Conjugates ADCs GettyImages-1438509824
    Antibody-Drug Conjugates

    Antibody drug conjugates (ADCs) are the emerging class of anti-cancer therapeutic drugs. ADCs combine an antibody capable of recognizing cancer cells and cytotoxic small-molecule drugs via cleavable or non-cleavable linkers, thereby transforming the 3-unit combination into a targeted therapeutic drug for cancer treatment. In recent years, ADCs have rapidly developed and there are not only more than 14 approved drugs on the market but also many investigational drugs undergoing clinical trials. Furthermore, ADCs have shown potential for treating various diseases beyond cancer, such as Autoimmune disorders, Infectious diseases, Inflammatory conditions and so on.  

WHITE PAPERS AND CASE STUDIES

NEWS

ABOUT

 

Catalysts

Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy.  For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.

Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.

All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present.  When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.

Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst.  Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.

Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature.  Applications of this technology include oil and petrochemical industries.